Related Experiment Video
Updated: May 3, 2026

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
Naming and framing in genomic testing
Eline M Bunnik1, Maartje H N Schermer1, A Cecile J W Janssens2
1Department of Medical Ethics and Philosophy of Medicine, Erasmus MC, University Medical Center Rotterdam, Room Na 21.02, PO Box 2400, 3000 CA Rotterdam, The Netherlands.
Terminology significantly influences ethical and regulatory discussions for genomic testing. Adopting a medical frame, prioritizing harm reduction, is proposed for evaluating and regulating predictive genomic tests.
Area of Science:
- Genomic Medicine
- Bioethics
- Health Policy
Background:
- Commercial genomic testing presents complex ethical and regulatory challenges.
- The language used to describe genomic tests influences public perception and policy.
- Existing terminology may not adequately address the nuances of predictive genomic information.
Discussion:
- This article examines the impact of naming and framing on the ethical and regulatory discourse of commercial genomic testing.
- It analyzes how different terminologies shape the perception of risk and benefit.
- The study advocates for a specific framing to guide regulatory approaches.
Key Insights:
- The choice of terminology is not neutral; it carries normative weight.
- A 'medical frame' emphasizes patient well-being and harm reduction.
- This framing is proposed as a basis for evaluating and regulating predictive genomic tests.
Outlook:
- Implementing a standardized medical frame could enhance ethical oversight.
- Consistent terminology may lead to more coherent and effective regulatory policies.
- Future research should explore the long-term impact of framing on genomic testing adoption and patient outcomes.
More Related Videos
05:51A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Related Concept Videos
Karyotyping
Labeling DNA Probes
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Sanger Sequencing
Genomics